EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomics in Traditional Chinese Medicine for Diabetes Mellitus: Mechanistic Insights, Biomarker Discovery, and Clinical Application Prospects

Junhui Song iD, Gen Lin Li iD, Suhui Wu iD, Hanbing Li iD

International Journal of Analytical Chemistry · 2026-01 · 2026 (1)

DOI: 10.1155/ianc/8261773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Analytical Chemistry, online erschienen am 15.05.2026. Verfasst von Junhui Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan, China, hactcm.edu.cn. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This review provides a comprehensive summary of recent advancements in metabolomic analysis within traditional Chinese medicine (TCM) for the treatment of diabetes mellitus. It focuses on the standardized profiling of syndrome‐specific metabolites, the identification of bioactive compounds using high‐throughput techniques, and the elucidation of mechanisms based on metabolic pathways. The review aims to establish a reproducible analytical framework for TCM metabolomics, which includes identifying active compounds, clarifying mechanisms of action, and assessing therapeutic efficacy. By synthesizing the current body of evidence, this work seeks to provide a scientific foundation for future research, enhance the integration of metabolomics with TCM theory, and support the modernization and global acceptance of TCM in diabetes care. Ultimately, it addresses key challenges, such as the subjective nature of syndrome diagnosis and the complexity of multicomponent interactions. Subjects and Methods A systematic review of the peer‐reviewed literature was conducted using PubMed, Web of Science, CNKI, and Wanfang Data for studies published up to 2025. The review included original research, reviews, and clinical trials that utilized metabolomic techniques (LC‐MS/MS, GC‐MS, and 600 MHz NMR) and standardized workflows (sample preparation, derivatization, instrument analysis, and data processing) in diabetic models. The qualitative synthesis focused on high‐throughput analytics, multivariate statistics (principal component analysis/partial least squares‐discriminant analysis [PCA/PLS‐DA] with 7‐fold cross‐validation and CV‐ANOVA, p < 0.05), and metabolite identification via the human metabolome database (HMDB)/METLIN metabolite database (mass error < 5 ppm); furthermore, these data were integrated with network pharmacology or multiomics approaches.

Results

Metabolomics has revealed distinct metabolic profiles for TCM syndromes. Specifically, the Qi‐Yin deficiency (QYD) syndrome is associated with altered levels of L‐glutamate (variable importance in projection [VIP] > 1, p < 0.05) and arachidonic acid (limit of detection [LOD] = 0.01–0.1 ng/mL), as well as the accumulation of turbid toxins involving pantothenate and CoA biosynthesis. Key hypoglycemic bioactive compounds, such as epicatechin and berberine, were identified using ultraperformance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry (UPLC‐QTOF‐MS), with a mass error of < 5 ppm. Mechanistic studies have shown that TCM works through multiple pathways, including improving insulin resistance (e.g., mulberry leaves modulating amino acid/lipid metabolism); protecting β‐cells (e.g., timosaponin BII restoring phosphatidylserine levels); regulating glycolipid metabolism (e.g., Huanglian decoction influencing energy‐related metabolites); modulating gut microbiota (e.g., Gegen Qinlian decoction altering bile acids and short‐chain fatty acids); and preventing complications (e.g., Sophora flavescens affecting oxidative stress through glycerophospholipid metabolism). Furthermore, metabolomics enabled efficacy comparisons, highlighting improved outcomes with nanoformulations or exercise‐TCM combinations.

Conclusions

Metabolomics provides a powerful approach to objectively assess TCM syndromes, clarify multitarget mechanisms, and comprehensively evaluate efficacy in diabetes treatment, which aligns well with TCM’s holistic principles. Despite existing challenges, such as the lack of standardized TCM syndrome classification and the complexity of metabolomic data (e.g., overlapping metabolite signals and multipathway crosstalk), future studies should focus on rigorous experimental designs, standardized protocols, and multiomics integration to promote biomarker discovery, personalized TCM, and its global integration into diabetes management.

Schlagwörter

Stichwörter der Autor:innen

analytical workflowbiomarker identificationdiabetes mellitusmetabolite profilingmetabolomicstraditional Chinese medicine

Autor:innen und Institutionen

  • School of Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan, China, hactcm.edu.cn.
  • Henan Province Health Aging Industry Research Center, Henan University of Chinese Medicine, Zhengzhou, Henan, China, hactcm.edu.cn.

ORCID-Profile: Junhui Song, Gen Lin Li, Suhui Wu, Hanbing Li

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Song, J., Li, G. L., Wu, S., & Li, H. (2026). Metabolomics in Traditional Chinese Medicine for Diabetes Mellitus: Mechanistic Insights, Biomarker Discovery, and Clinical Application Prospects. International Journal of Analytical Chemistry, 2026(1). https://doi.org/10.1155/ianc/8261773

Vancouver

Song J, Li GL, Wu S, Li H. Metabolomics in Traditional Chinese Medicine for Diabetes Mellitus: Mechanistic Insights, Biomarker Discovery, and Clinical Application Prospects. International Journal of Analytical Chemistry. 2026;2026(1). doi:10.1155/ianc/8261773

BibTeX
@article{Song2026,
  author = {Song, Junhui and Li, Gen Lin and Wu, Suhui and Li, Hanbing},
  title = {Metabolomics in Traditional Chinese Medicine for Diabetes Mellitus: Mechanistic Insights, Biomarker Discovery, and Clinical Application Prospects},
  journal = {International Journal of Analytical Chemistry},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ianc/8261773}
}
Kostenlos starten →